<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Angiogenic factors have an essential role in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:mp ids='MP_0003711'>pathologic angiogenesis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the clinical implication of angiogenic factor expression in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In this study, we sought to investigate the prognostic impact of the expression of genes encoding angiopoietin-1 (Ang-1), Ang-2, the receptor Tie2, vascular endothelial growth factor-A (VEGF-A) and VEGF-C in the bone marrow (BM) in 208 patients with newly diagnosed primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: BM Ang-1 expression was significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, especially those with higher-risk subtypes, than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="4" pm="."><plain>With a median follow-up time of 32.9 months, the disease transformed to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> more frequently in the patients bearing higher Ang-1 expression than in those with lower expression (31.5% vs 18.6%, P=0.023) </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with higher Ang-1 expression had shorter overall survival than those with lower expression (median 20.8±4.5 months vs 63.3±17.8 months, P&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate analyses showed that higher Ang-1 expression was an independent unfavourable prognostic factor for overall survival </plain></SENT>
<SENT sid="7" pm="."><plain>There was no impact of the expression of other angiogenic factors on survival </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: BM Ang-1 expression may serve as a new biomarker to predict clinical outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>